Personalized medicine: Europe’s seeds are sown but not yet grown
To truly improve patients’ lives through personalized medicine, the seeds of innovation must be sown, and its capacity must be grown. Europe undoubtedly excels as an R&D hub, yet we fall behind when transforming ideas into tangible products and services. So how can we create an environment where personalized medicine can flourish and deliver real solutions for patients? That question was the focus of a recent meeting at the European Parliament where the PRECISEU consortium brought together key stakeholders to discuss the future of the field.
Header Photo by Biocat, BioRegió de Catalunya, © 2025, licensed under CC BY-NC-SA 4.0. Regions for Health Innovation: Personalised Medicine and ATMPs driving Europe’s Future.
Personalized medicine moves beyond the one-size-fits-all approach of traditional medicine—embracing the unique variability of each individual’s genetics, environment and lifestyle, and tailoring prevention and treatment to their specific needs. This not only improves patient outcomes but also ensures a more efficient use of public resources.